Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV03
- Pharmacological subgroupV03A
- Chemical subgroupV03AF
- Chemical substanceV03AF07Rasburicase
Where it is registered
Each register and historical list with its number of registrations and a few of them.
At a glance
- ATC code
- V03AF07
- ATC group
- Various
- Registers
- 9
- Historical lists
- 1
- Registrations
- 16
- With their own page
- 11
- Companies
- 11
All medicines with Rasburicase
Human medicines from every register that match Rasburicase by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
16 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Elitek | United States | 1.5MG/VIAL | vial | Marketed | Sanofi Synthelabo |
| Elitek | United States | 7.5MG | For Injection | Marketed | Sanofi-Aventis U.S. LLC |
| Fasturtec | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Fasturtec 1,5 MG/ML Polvo y Disolvente Para Concentrado Para Solucion Para Perfusion | Spain | 1,5 mg | polvo y disolvente para concentrado para solución para perfusión | Marketed | Sanofi Winthrop Industrie |
| Fasturtec 1,5 mg/ml poeder en oplosmiddel voor concentraat voor oplossing voor infusie | Netherlands | Poeder en oplosmiddel voor concentraat voor oplossing voor infusie | Authorised | Sanofi Winthrop Industrie | |
| Fasturtec 1,5 MG/ML Polvo y Disolvente Para Concentrado Para Solucion Para Perfusion | Spain | 7,5 mg | polvo y disolvente para concentrado para solución para perfusión | Authorised | Sanofi Winthrop Industrie |
| Fasturtec | Canada | 1.5 MG / VIAL | Powder For Solution | Marketed | Sanofi-Aventis Canada INC |
| Fasturtec | Brazil | Authorised | Sanofi Medley Farmacêutica Ltda. | ||
| FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial | Singapore | 1.5 mg/vial | injection, powder, for solution | Authorised | Sanofi-Aventis Singapore Pte. LTD. |
| Fasturtec | Croatia | Marketed | |||
| Any | New Zealand | Inj 1.5 mg vial | Funded | ||
| Fasturtec | Saudi Arabia | Authorised | sanofi S.P.A | ||
| Fasturtec | Saudi Arabia | Authorised | sanofi S.P.A | ||
| Fasturtec | Brazil | Cancelled | Sanofi - Synthelabo Farmacêutica Ltda | ||
| Fasturtec | Canada | 7.5 MG / VIAL | Powder For Solution | Cancelled | Sanofi-Aventis Canada INC |
| Fasturtec | Brazil | Cancelled | Sanofi-Aventis Farmacêutica Ltda |